These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 38031771)
1. MicroRNA3650 Promotes Gastric Cancer Proliferation and Migration through the PTEN/PI3K-AKT-mTOR and Hippo Pathways. Yang X; Wen J; He Q; Wang S; Ruan Q; Liao Q; He J; Fang S; Liu C; Tang H Protein Pept Lett; 2023; 30(11):966-973. PubMed ID: 38031771 [TBL] [Abstract][Full Text] [Related]
2. miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway. Riquelme I; Tapia O; Leal P; Sandoval A; Varga MG; Letelier P; Buchegger K; Bizama C; Espinoza JA; Peek RM; Araya JC; Roa JC Cell Oncol (Dordr); 2016 Feb; 39(1):23-33. PubMed ID: 26458815 [TBL] [Abstract][Full Text] [Related]
3. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling. Ding X; Xu X; He XF; Yuan Y; Chen C; Shen XY; Su S; Chen Z; Xu ST; Huang YH Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424 [TBL] [Abstract][Full Text] [Related]
4. miR-21 Inhibitors Modulate Biological Functions of Gastric Cancer Cells via PTEN/PI3K/mTOR Pathway. Wang P; Guan Q; Zhou D; Yu Z; Song Y; Qiu W DNA Cell Biol; 2018 Jan; 37(1):38-45. PubMed ID: 29185784 [TBL] [Abstract][Full Text] [Related]
5. The Gene Expression Status of the PI3K/AKT/mTOR Pathway in Gastric Cancer Tissues and Cell Lines. Riquelme I; Tapia O; Espinoza JA; Leal P; Buchegger K; Sandoval A; Bizama C; Araya JC; Peek RM; Roa JC Pathol Oncol Res; 2016 Oct; 22(4):797-805. PubMed ID: 27156070 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA BX357664 inhibits gastric cancer progression by sponging miR-183a-3p to regulate the PTEN expression and PI3K/AKT pathway. Liang LC; Liu LQ; Liu L; Liu DL; He YR; Wan X; Zhu ZQ; Zhang BG; Liu SJ; Wu H; Hu L Food Chem Toxicol; 2021 Apr; 150():112069. PubMed ID: 33607219 [TBL] [Abstract][Full Text] [Related]
7. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway. Luo X; Dong J; He X; Shen L; Long C; Liu F; Liu X; Lin T; He D; Wei G Biomed Pharmacother; 2020 May; 125():109880. PubMed ID: 32004974 [TBL] [Abstract][Full Text] [Related]
8. The GAS5/miR-222 Axis Regulates Proliferation of Gastric Cancer Cells Through the PTEN/Akt/mTOR Pathway. Li Y; Gu J; Lu H Dig Dis Sci; 2017 Dec; 62(12):3426-3437. PubMed ID: 29098549 [TBL] [Abstract][Full Text] [Related]
9. miR-188-5p emerges as an oncomiRNA to promote gastric cancer cell proliferation and migration via upregulation of SALL4. Wang M; Qiu R; Gong Z; Zhao X; Wang T; Zhou L; Lu W; Shen B; Zhu W; Xu W J Cell Biochem; 2019 Sep; 120(9):15027-15037. PubMed ID: 31009138 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis. Lu C; Shan Z; Hong J; Yang L Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966 [TBL] [Abstract][Full Text] [Related]
11. The effect of miR-579 on the PI3K/AKT pathway in human glioblastoma PTEN mutant cell lines. Kalhori MR; Irani S; Soleimani M; Arefian E; Kouhkan F J Cell Biochem; 2019 Oct; 120(10):16760-16774. PubMed ID: 31243804 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-28 promotes cell proliferation and invasion in gastric cancer via the PTEN/PI3K/AKT signalling pathway. Li L; Zhu X; Shou T; Yang L; Cheng X; Wang J; Deng L; Zheng Y Mol Med Rep; 2018 Mar; 17(3):4003-4010. PubMed ID: 29257342 [TBL] [Abstract][Full Text] [Related]
13. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis. Xu W; Yang Z; Xie C; Zhu Y; Shu X; Zhang Z; Li N; Chai N; Zhang S; Wu K; Nie Y; Lu N J Exp Clin Cancer Res; 2018 Aug; 37(1):198. PubMed ID: 30134988 [TBL] [Abstract][Full Text] [Related]
14. METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway. Bi X; Lv X; Liu D; Guo H; Yao G; Wang L; Liang X; Yang Y Cancer Gene Ther; 2021 Apr; 28(3-4):335-349. PubMed ID: 32939058 [TBL] [Abstract][Full Text] [Related]
15. miR-20b and miR-451a Are Involved in Gastric Carcinogenesis through the PI3K/AKT/mTOR Signaling Pathway: Data from Gastric Cancer Patients, Cell Lines and Ins-Gas Mouse Model. Streleckiene G; Inciuraite R; Juzenas S; Salteniene V; Steponaitiene R; Gyvyte U; Kiudelis G; Leja M; Ruzgys P; Satkauskas S; Kupcinskiene E; Franke S; Thon C; Link A; Kupcinskas J; Skieceviciene J Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013265 [TBL] [Abstract][Full Text] [Related]
16. Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway. Li J; Ye D; Shen P; Liu X; Zhou P; Zhu G; Xu Y; Fu Y; Li X; Sun J; Xu J; Zhang Q J Exp Clin Cancer Res; 2020 Oct; 39(1):212. PubMed ID: 33032635 [TBL] [Abstract][Full Text] [Related]
17. Kaempferol inhibits proliferation, migration, and invasion of liver cancer HepG2 cells by down-regulation of microRNA-21. Zhu G; Liu X; Li H; Yan Y; Hong X; Lin Z Int J Immunopathol Pharmacol; 2018; 32():2058738418814341. PubMed ID: 30477356 [TBL] [Abstract][Full Text] [Related]
18. MiR-592 Promotes Gastric Cancer Proliferation, Migration, and Invasion Through the PI3K/AKT and MAPK/ERK Signaling Pathways by Targeting Spry2. He Y; Ge Y; Jiang M; Zhou J; Luo D; Fan H; Shi L; Lin L; Yang L Cell Physiol Biochem; 2018; 47(4):1465-1481. PubMed ID: 29949784 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway. Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399 [TBL] [Abstract][Full Text] [Related]
20. MiR-647 promotes proliferation and migration of ox-LDL-treated vascular smooth muscle cells through regulating PTEN/PI3K/AKT pathway. Xu CX; Xu L; Peng FZ; Cai YL; Wang YG Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):7110-7119. PubMed ID: 31486513 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]